Parecoxib protects against myocardial ischemia/reperfusion via targeting PKA-CREB signaling pathway
Panminerva Med
.
2022 Dec;64(4):587-588.
doi: 10.23736/S0031-0808.19.03775-3.
Epub 2020 Jan 20.
Authors
Jiandong Gao
1
,
Guifang Zhao
2
,
Pengfei Wang
3
,
Shaozhen Li
4
,
Xiyan Wang
5
,
Hongyan Zhao
6
Affiliations
1
Department of Pain Clinic, Yantaishan Hospital, Yantai, China.
2
Department of Clinical Pharmacy, Jiyang People's Hospital, Jinan, China.
3
Department of Critical Care Medicine, the People's Hospital of Zhangqiu Area, Jinan, China.
4
Department of Imaging, the People's Hospital of Zhangqiu Area, Jinan, China.
5
Department of Anesthesiology, the People's Hospital of Zhangqiu Area, Jinan, China.
6
Department of Health Care, Jinan Central Hospital, Jinan, China - hospitalzx@163.com.
PMID:
31961110
DOI:
10.23736/S0031-0808.19.03775-3
No abstract available
MeSH terms
Apoptosis
Humans
Isoxazoles
Myocardial Reperfusion Injury* / prevention & control
Signal Transduction
Substances
parecoxib
Isoxazoles